Skip to main content
. 2017 Jan 3;8(12):19507–19521. doi: 10.18632/oncotarget.14470

Figure 2. MiR-24 regulates the response to cisplatin in breast cancer cells.

Figure 2

A, B, C. miR-24 transfection increased cisplatin resistance in T47D, BT-549, and MDA-MB-231 cells as assessed by Caspase-3/7 assay and D, E. by Western blot for cleaved PARP and Caspase-3. F, G. Anti-miR-24 transfection increased sensibility to cisplatin in MDA-MB-231 cancer stem cells. Western blots show representative experiments. Data are mean values ± SD of three independent experiments. In A, B, and F, significance was calculated using Student's t-test.*, p<0.05; **, p<0.01.